Disease-specific prevalence of red flags for rare diseases in patients presenting with a Hypertrophic Cardiomyopathy phenotype

被引：0

作者：

Maurizi, Niccolo ^{[1
]}

Monda, Emanuele ^{[2
]}

Biagini, Elena ^{[3
]}

Fumagalli, Carlo ^{[4
]}

Cecchi, Franco ^{[4
]}

Monney, Pierre ^{[1
]}

Elliott, Perry ^{[5
,6
]}

Limongelli, Giuseppe ^{[2
]}

Kasky, Juan Pablo ^{[7
]}

Olivotto, Iacopo ^{[4
]}

机构：

[1] Univ Lausanne Hosp, Serv Cardiol, Lausanne, Switzerland

[2] Univ Campania Luigi Vanvitelli, Monaldi Hosp, Dept Traslat Med Sci, Inherited & Rare Cardiovasc Dis Unit, Naples, Italy

[3] St Orsola Marcello Malpighi Hosp, Serv Cardiol, Bologna, Italy

[4] Careggi Univ Hosp, Cardiomyopathy Unit, Florence, Italy

[5] UCL, Inst Cardiol Sci, Ctr Heart Muscle Dis, London, England

[6] St Bartholomews Hosp, London, England

[7] Great Ormond St Hosp Sick Children, Ctr Inherited Cardiovasc Dis, Great Ormond St, London, England

来源：

SWISS MEDICAL WEEKLY | 2023年 / 153卷

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

O29

引用

页码：30S / 30S

页数：1

共 50 条

[1] Hypertrophic cardiomyopathy: prevalence of disease-specific red flags
Maurizi, Niccolo
Monda, Emanuele
Biagini, Elena
Field, Ella
Passantino, Silvia
Dall' Aglio, Gabriella
Fumagalli, Carlo
Antiochos, Panagiotis
Skalidis, Ioannis
Pieroni, Maurizio
Argiro, Alessia
Girolami, Francesca
Cecchi, Franco
Barbey, Frederic
Monney, Pierre
Elliott, Perry M.
Kaski, Juan Pablo
Limongelli, Giuseppe
Olivotto, Iacopo
EUROPEAN HEART JOURNAL, 2025,
[2] Prevalence and clinical correlates of clinical red flags for rare diseases in consecutive patients presenting with HCM phenotype
Maurizi, N.
Dall'aglio, G.
Fumagalli, C.
Argiro, A.
Olivotto, I.
EUROPEAN HEART JOURNAL, 2022, 43 : 1732 - 1732
[3] Prevalence and clinical significance of red flags in patients with hypertrophic cardiomyopathy
Limongelli, Giuseppe
Monda, Emanuele
Tramonte, Stefania
Gragnano, Felice
Masarone, Daniele
Frisso, Giulia
Esposito, Augusto
Gravino, Rita
Ammendola, Ernesto
Salerno, Gemma
Rubino, Marta
Caiazza, Martina
Russo, Mariagiovanna
Calabro, Paolo
Elliott, Perry Mark
Pacileo, Giuseppe
INTERNATIONAL JOURNAL OF CARDIOLOGY, 2020, 299 : 186 - 191
[4] Prevalence and clinical significance of red flags in patients with hypertrophic cardiomyopathy
Monda, Emanuele
Tramonte, Stefania
Gragnano, Felice
Masarone, Daniele
Frisso, Giulia
Esposito, Augusto
Gravino, Rita
Ammendola, Ernesto
Salerno, Gemma
Rubino, Marta
Caiazza, Martina
Russo, Maria Giovanna
Calabro, Paolo
Elliott, Perry Mark
Pacileo, Giuseppe
Limongelli, Giuseppe
EUROPEAN HEART JOURNAL SUPPLEMENTS, 2019, 21 (0J) : J186 - J186
[5] Mavacamten: A Novel Disease-Specific Treatment for Hypertrophic Cardiomyopathy
Capilupi, Michael J.
Frishman, William H.
CARDIOLOGY IN REVIEW, 2023, 31 (01) : 45 - 51
[6] Mavacamten - a new disease-specific option for pharmacological treatment of symptomatic patients with hypertrophic cardiomyopathy
Pysz, Piotr
Rajtar-Salwa, Renata
Smolka, Grzegorz
Olivotto, Iacopo
Wojakowski, Wojciech
Petkow-Dimitrow, Pawel
KARDIOLOGIA POLSKA, 2021, 79 (09) : 949 - 954
[7] Prevalence of fabry disease in patients with hypertrophic cardiomyopathy
Azevedo, O.
Marques, N.
Reis, L.
Gomes, A.
Abreu, L.
Domingues, K.
Santos, R.
Leao, S.
Picarra, B.
Lima, R.
Faria, R.
Fonseca, C.
Sousa, N.
Cunha, D.
EUROPEAN HEART JOURNAL, 2016, 37 : 1152 - 1152
[8] Prevalence and Characteristics of Hypertrophic Cardiomyopathy Phenotype in Patients with Cardiac Sarcoidosis
Zia, Abdul
Lal, Mallika
Nazer, Babak
Levin, Benjamin
Masri, Ahmad
CIRCULATION, 2024, 150
[9] Rare inherited diseases merit disease-specific trials
Durr, Alexandra
LANCET NEUROLOGY, 2015, 14 (10): : 968 - 969
[10] A rare phenotype of heterozygous Danon disease mimicking apical hypertrophic cardiomyopathy
Yu, Liuyu
Wan, Ke
Han, Yuchi
Chen, Yucheng
EUROPEAN HEART JOURNAL, 2018, 39 (34) : 3263 - 3264

← 1 2 3 4 5 →